Insights from AUA 2024 Annual Meeting


 

AUA 2024 Insights: "MoonRISe-1 Study - Erdafitinib-Releasing Intravesical Delivery System (TAR-210) vs. Intravesical Chemo in Intermediate-Risk NMIBC With FGFR Alterations"

70 views
May 23, 2024
Comments 0
Login to view comments. Click here to Login